Veraxa Biotech Holding AG carries a market capitalization of 253.12M, placing it among publicly traded companies globally.
| Market Cap | 253.12M |
| Enterprise Value | N/A |
Veraxa Biotech Holding AG's stock has declined approximately -85.38776% over the past 52 weeks. The 50-day moving average sits at 4.58, while the 200-day moving average is 9.40.
| Beta (5Y) | N/A |
| 52-Week Price Change | -85.38776% |
| 50-Day Moving Average | 4.58 |
| 200-Day Moving Average | 9.40 |
| Average Volume (20 Days) | N/A |